Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
38363
CAS Number:
19545-26-7
Wortmanina
Purity:
≥ 98 % (HPLC)
Synonym(s):
Kentucky 12420
Hazmat
Documents
$294.24 /20 mg
Tamaño
Request Bulk Quote
Información del producto
Número CAS
19545-26-7
Fórmula molecular
C23H24O8
Peso molecular
0
Número MDL
MFCD00133927
Punto de fusión
235 - 239 °C
Rotación óptica
85 - 89° (C=0,17, CHCl3)
Condiciones
Conservar a < -20 °C
Información general
Número CAS
19545-26-7
Fórmula molecular
C23H24O8
Peso molecular
0
Número MDL
MFCD00133927
Punto de fusión
235 - 239 °C
Rotación óptica
85 - 89° (C=0,17, CHCl3)
Condiciones
Conservar a < -20 °C
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Wortmannin is widely utilized in research focused on various applications:

  • Cancer Research: This compound is a potent inhibitor of phosphoinositide 3-kinase (PI3K), making it valuable in studying cancer cell signaling pathways. Researchers use it to explore potential treatments for various cancers by understanding how PI3K inhibition affects tumor growth.
  • Neuroscience: Wortmannin is employed to investigate the role of PI3K in neuronal survival and differentiation. Its application helps in understanding neurodegenerative diseases and developing neuroprotective strategies.
  • Cardiovascular Studies: By inhibiting PI3K, this compound aids in exploring its effects on cardiac function and signaling pathways, which can lead to new insights into heart diseases and potential therapeutic targets.
  • Immunology: Researchers utilize wortmannin to study immune cell signaling and function. Its ability to modulate immune responses makes it a useful tool in developing treatments for autoimmune diseases.
  • Drug Development: As a research tool, wortmannin helps in the screening of new drug candidates targeting PI3K pathways. Its specificity allows scientists to better understand the mechanisms of action of potential therapeutics.

Citas